Oleksii Korzh / Корж Олексій
Oleksii Korzh / Корж Олексій
Харківська медична академія післядипломної освіти
Підтверджена електронна адреса в med.edu.ua
Назва
Посилання
Посилання
Рік
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England Journal of Medicine 376 (18), 1713-1722, 2017
25962017
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
23792010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
N Engl j Med 369, 1327-1335, 2013
23332013
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari, Beautiful Investigators
The Lancet 372 (9641), 807-816, 2008
12462008
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
8782019
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
7852011
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
F Zannad, CP Cannon, WC Cushman, GL Bakris, V Menon, AT Perez, ...
The Lancet 385 (9982), 2067-2076, 2015
6102015
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
N Engl j Med 368, 513-523, 2013
5072013
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari
New England Journal of Medicine 371 (12), 1091-1099, 2014
4532014
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
MR Weir, GL Bakris, DA Bushinsky, MR Mayo, D Garza, Y Stasiv, J Wittes, ...
New England Journal of Medicine 372 (3), 211-221, 2015
4202015
Darapladib for preventing ischemic events in stable coronary heart disease
Stability Investigators
New England Journal of Medicine 370 (18), 1702-1711, 2014
3942014
Tiotropium Respimat inhaler and the risk of death in COPD
RA Wise, A Anzueto, D Cotton, R Dahl, T Devins, B Disse, D Dusser, ...
N Engl J Med 369, 1491-1501, 2013
3872013
Эндотелиальная дисфункция при патологии сердечно-сосудистой системы
ЛТ Малая, АН Корж, ЛБ Балковая
Харьков: Торсинг 432, 2000
3812000
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics
MJ Jardine, KW Mahaffey, B Neal, R Agarwal, GL Bakris, BM Brenner, ...
American journal of nephrology 46 (6), 462-472, 2017
1332017
Beclomethasone/formoterol in the management of COPD: a randomised controlled trial
PMA Calverley, P Kuna, E Monso, M Costantini, S Petruzzelli, F Sergio, ...
Respiratory medicine 104 (12), 1858-1868, 2010
1122010
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction–baseline characteristics of the …
VM Maria da Consolação, S Heringer-Walther, N Wessel, TM Ventura, ...
Cardiology 110 (4), 271-282, 2008
752008
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The Lancet Respiratory Medicine 7 (1), 46-59, 2019
622019
Современные представления о структуре, функции и биологической роли сосудистого эндотелия
АН Корж
Международный медицинский журнал, 2003
57*2003
Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE trial
WB White, S Kupfer, F Zannad, CR Mehta, CA Wilson, L Lei, GL Bakris, ...
Diabetes Care 39 (7), 1267-1273, 2016
532016
Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups: results …
KW Mahaffey, MJ Jardine, S Bompoint, CP Cannon, B Neal, ...
Circulation 140 (9), 739-750, 2019
482019
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20